dr tyna moore tirzepatide The Miraculous Benefits of Ozempic: Expert Insights with Dr. Tina Moore & James

Overlapping digestive symptoms require careful monitoring

0.6% with placebo at 68 weeks Dose escalation schedule / 0.25 mg weekly for 4 weeks, escalating to 2.4 mg over 16 weeks AAP guideline threshold / pharmacotherapy considered at age 12 or older with obesity Growth monitoring / required at every visit for all pediatric patients on GLP-1 therapy Off-label use in under-12 / not recommended by any major guideline body FDA Approval Covers Ages 12 and Up Only Wegovy received expanded approval from the FDA in December 2022 for adolescents aged 12 years and older with a body mass index at or above the 95th percentile for age and sex [1]

Advanced compound for NNMT pathway studies

Couzin-Frankel 6 Sept 2023